Marco Dolci - LivaNova PLC Pres Unit
| LIVN Stock | USD 60.19 0.88 1.44% |
Insider
Marco Dolci is Pres Unit of LivaNova PLC
| Age | 62 |
| Address | 20 Eastbourne Terrace, London, United Kingdom, W2 6LG |
| Phone | 44 20 3325 0660 |
| Web | https://www.livanova.com |
LivaNova PLC Management Efficiency
The company has return on total asset (ROA) of 0.0264 % which means that it generated a profit of $0.0264 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0259) %, meaning that it created substantial loss on money invested by shareholders. LivaNova PLC's management efficiency ratios could be used to measure how well LivaNova PLC manages its routine affairs as well as how well it operates its assets and liabilities. As of the 4th of June 2024, Return On Tangible Assets is likely to grow to 0.01. Also, Return On Capital Employed is likely to grow to 0.05. At this time, LivaNova PLC's Intangible Assets are very stable compared to the past year. As of the 4th of June 2024, Net Tangible Assets is likely to grow to about 116.1 M, while Deferred Long Term Asset Charges is likely to drop about 4.8 M.Similar Executives
| Found 5 records | INSIDER Age | ||
| Xavier MS | bioAffinity Technologies Warran | 54 | |
| Udi MD | Inspira Technologies Oxy | 41 | |
| Dagi BenNoon | Inspira Technologies Oxy | 48 | |
| Maria JD | bioAffinity Technologies Warran | 68 | |
| Joe Hayon | Inspira Technologies Oxy | 50 | |
Management Performance
| Return On Equity | -0.0259 | ||||
| Return On Asset | 0.0264 |
LivaNova PLC Leadership Team
Elected by the shareholders, the LivaNova PLC's board of directors comprises two types of representatives: LivaNova PLC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of LivaNova. The board's role is to monitor LivaNova PLC's management team and ensure that shareholders' interests are well served. LivaNova PLC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, LivaNova PLC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lindsey Little, Director Relations | ||
| Damien McDonald, CEO Director | ||
| William Kozy, Chairman CEO | ||
| Stephanie Bolton, President Epilepsy | ||
| Matthew III, Senior IT | ||
| Badri Amurthur, Chief Officer | ||
| Trui Hebbelinck, Chief Human Resource Officer | ||
| Deanna Wilke, Vice Communications | ||
| John Webb, Vice Epilepsy | ||
| Keyna Skeffington, Senior Vice President General Counsel | ||
| Michael Hutchinson, Chief VP | ||
| Ryan Miller, President Support | ||
| Alex Shvartsburg, Chief Officer | ||
| Bryan Olin, Senior Neuromodulation | ||
| Vladimir Makatsaria, CEO Director | ||
| Marco Dolci, Pres Unit | ||
| Jonathan Walker, VP Segment |
LivaNova Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is LivaNova PLC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0259 | ||||
| Return On Asset | 0.0264 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 3.67 B | ||||
| Shares Outstanding | 54.15 M | ||||
| Shares Owned By Insiders | 0.29 % | ||||
| Shares Owned By Institutions | 99.71 % | ||||
| Number Of Shares Shorted | 2.74 M | ||||
| Price To Earning | 78.67 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in LivaNova Stock
When determining whether LivaNova PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of LivaNova PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Livanova Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Livanova Plc Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LivaNova PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. To learn how to invest in LivaNova Stock, please use our How to Invest in LivaNova PLC guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LivaNova PLC. If investors know LivaNova will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LivaNova PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 9.026 | Earnings Share (0.60) | Revenue Per Share 21.93 | Quarterly Revenue Growth 0.12 | Return On Assets 0.0264 |
The market value of LivaNova PLC is measured differently than its book value, which is the value of LivaNova that is recorded on the company's balance sheet. Investors also form their own opinion of LivaNova PLC's value that differs from its market value or its book value, called intrinsic value, which is LivaNova PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LivaNova PLC's market value can be influenced by many factors that don't directly affect LivaNova PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LivaNova PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if LivaNova PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LivaNova PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.